| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lexeo Therapeutics, Inc. (LXEO) has 13 insiders with recent SEC Form 4 filings, including 3 buys and 3 sells. LXEO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 395.1K | $2.30M | - | |
| COO | 131.4K | $766.0K | - | |
| Other | 72.6K | $423.5K | - | |
| Other | 68.4K | $398.7K | - | |
| Other | 65.5K | $381.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2024 | Townsend Richard Nolan76 | Chief Executive Officer | Sale+OE | 5,000 | $17.65 | $88,263.82 | -1.4% | -42.2% | -75.4% | |
| May 13, 2024 | Townsend Richard Nolan76 | Chief Executive Officer | Sale+OE | 5,000 | $13.22 | $66,093.00 | -2.8% | -11.7% | -79.1% | |
| Nov 7, 2023 | Lundbeckfond Invest A/s | 10% Owner | Buy | 227,272 | $11.00 | $2,499,992.00 | +14.1% | +61.6% | -21.6% | |
| Nov 7, 2023 | Omega Fund Vi, L.P. | 10% Owner | Buy | 454,545 | $11.00 | $4,999,995.00 | +26.7% | +61.6% | -21.6% | |
| Nov 7, 2023 | Longitude Capital Partners Iv, LLC63 | 10% Owner | Buy | 454,545 | $11.00 | $4,999,995.00 | +21.5% | +61.6% | -21.6% |